Related Experiment Video
Updated: May 5, 2026

09:17
Using Retinal Imaging to Study Dementia
Published on: November 7, 2017
21.1K
An ensemble machine learning classifier for Parkinson's disease diagnosis using optical coherence tomography
MohammadReza Hasanshahi1, Alireza Mehdizadeh2,3, Tahereh Mahmoudi4,5,6
1Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Scientific Reports
|February 4, 2026
Summary
Retinal microvascular changes detected by Optical Coherence Tomography Angiography (OCTA) show promise as non-invasive biomarkers for early Parkinson
Area of Science:
- Ophthalmology
- Neurology
- Medical Imaging
Background:
- Parkinson's disease (PD) diagnosis is challenging due to a lack of early biomarkers.
- Retinal microvascular alterations detected via OCTA are emerging as potential non-invasive PD biomarkers.
- Objective, non-invasive tools are crucial for timely PD detection and intervention.
Purpose of the Study:
- To investigate the utility of OCTA-derived retinal vascular features for classifying Parkinson's disease.
- To develop and validate a machine learning model for PD detection using retinal imaging data.
Main Methods:
- Retrospective analysis of OCTA images from 53 PD patients and 39 healthy controls.
- Segmentation of superficial and deep vascular complexes to extract 22 quantitative features.
- Application of a multi-stage feature selection framework and ensemble machine learning models (XGBoost, Random Forest, KNN).
Main Results:
- An ensemble model achieved 74.28% accuracy, 90% sensitivity, 53.33% specificity, and 0.75 AUC on an independent test set.
- Key features included morphological descriptors (form factor, convexity, solidity, roundness) and vascular density (VAD, VSD).
- A user-friendly graphical interface (PDAI) was developed for clinical application.
Conclusions:
- OCTA-based retinal vascular analysis offers a promising non-invasive approach for Parkinson's disease classification and screening.
- The developed AI framework supports early PD detection, requiring further validation in larger, multi-center studies.
Keywords:
Ensemble learningMachine learningOptical coherence tomography angiography (OCTA)Parkinson’s diseaseMore Related Videos
Related Concept Videos
Computed Tomography
7.6K
Tomography refers to imaging by sections. Computed tomography (CT) is a non-invasive imaging technique that uses computers to analyze several cross-sectional X-rays to reveal minute details about structures in the body.
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...
7.6K
Positron Emission Tomography
6.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.2K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28

